Literature DB >> 7692027

Immunohistochemical comparison of cutaneous histiocytoses and related skin disorders: diagnostic and histogenetic relevance of MS-1 high molecular weight protein expression.

S Goerdt1, G Kolde, G Bonsmann, K Hamann, B Czarnetzki, R Andreesen, T Luger, C Sorg.   

Abstract

Twenty-nine cases of Langerhans cell histiocytosis (LCH), non-Langerhans cell histiocytoses (N-LCH), non-infectious granulomas, and fibroblast-related lesions were examined with a panel of monoclonal and polyclonal antibodies on freshly frozen tissue sections to characterize the macrophage phenotype of N-LCH syndromes. MS-1 high molecular weight extracellular protein, specific for sinusoidal endothelial cells and dendritic perivascular macrophages in normal human organs, was expressed by N-LCH cells but was not found in LCH cells, epithelioid cells in sarcoidosis, or palisading histiocytes in granuloma annulare. The subcellular location of MS-1 protein, i.e., cytoplasmic vs. peripheral/extracellular, allowed discrimination of small and large (foamy or multinucleated) N-LCH cells. MS-1-positive cells, which were found intermingled in cellular dermatofibromas but not in fibrous dermatofibromas, differed from MS-1-positive N-LCH cells by their dendritic morphology, and thus rather resembled their normal dermal counterparts. A preserved functional relationship of these two MS-1-positive cell types was indicated by the fact that N-LCH and cellular dermatofibromas were the only lesions found to be highly vascularized. As expected, CD1a showed high specificity for LCH, while CD34 was predominantly expressed by fibroblast-related lesions; in cellular dermatofibromas, CD34 and MS-1 expression partially overlapped. The other antigens tested showed non-specific or overlapping patterns of expression. In conclusion, assessment of MS-1 protein expression (in addition to assessment of CD1a and CD34) promises to be of diagnostic value in the discrimination of N-LCH from related skin disorders, and it may indicate a common differentiative pathway for most N-LCH disease entities.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7692027     DOI: 10.1002/path.1711700404

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  4 in total

1.  Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues.

Authors:  Oliver Politz; Alexei Gratchev; Peter A G McCourt; Kai Schledzewski; Pierre Guillot; Sophie Johansson; Gunbjorg Svineng; Peter Franke; Christoph Kannicht; Julia Kzhyshkowska; Paola Longati; Florian W Velten; Staffan Johansson; Sergij Goerdt
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

2.  Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro.

Authors:  C Schebesch; V Kodelja; C Müller; N Hakij; S Bisson; C E Orfanos; S Goerdt
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

3.  Expression of stabilin-1 in M2 macrophages in human granulomatous disease and melanocytic lesions.

Authors:  Kathrin Schönhaar; Kai Schledzewski; Julia Michel; Claudia Dollt; Cleopatra Gkaniatsou; Cyrill Géraud; Julia Kzhyshkowska; Sergij Goerdt; Astrid Schmieder
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

Review 4.  Stabilin-1, a homeostatic scavenger receptor with multiple functions.

Authors:  Julia Kzhyshkowska; A Gratchev; S Goerdt
Journal:  J Cell Mol Med       Date:  2006 Jul-Sep       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.